COMMONS CAPITAL, LLC RXRX — RECURSION PHARMACEUTICALS IN

Ownership history in COMMONS CAPITAL, LLC  ·  8 quarters on record

AI Ownership Summary

COMMONS CAPITAL, LLC reported RECURSION PHARMACEUTICALS IN (RXRX) in 8 quarterly 13F filings from 2024 Q2 through 2026 Q1. Peak portfolio weight reached 1.0% in 2024 Q2. The latest visible filing shows RXRX at 0.03% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this RXRX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was COMMONS CAPITAL, LLC's position in RECURSION PHARMACEUTICALS IN, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

RXRX was reported at 0.03% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
1.0% in 2024 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q2 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

RXRX stock page COMMONS CAPITAL, LLC fund profile COMMONS CAPITAL, LLC full holdings
How COMMONS CAPITAL, LLC held RXRX — position size vs. price
% of Fund (quarterly)    RXRX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 8 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED — — — 10,620 -1,870 -15.0% 0.03% $33K 2026-04-30 $3.46
2025 Q4 REDUCED 89.5% -24.9% ✅ 12,490 -106,818 -89.5% 0.03% $51K 2026-01-05 $4.37
2025 Q3 ADDED — — — 119,308 +1,786 +1.5% 0.38% $582K 2025-11-12 $4.65
2025 Q2 ADDED — — — 117,522 +8,426 +7.7% 0.45% $595K 2025-07-29 $5.95
2025 Q1 ADDED — — — 109,096 +576 +0.5% 0.53% $577K 2025-05-12 $4.64
2024 Q4 REDUCED 6.4% -21.8% ✅ 108,520 -7,439 -6.4% 0.66% $734K 2025-01-17 $6.53
2024 Q3 ADDED — — — 115,959 +4,852 +4.4% 0.84% $764K 2024-10-23 $6.33
2024 Q2 INITIATED — — — 111,107 — — 1.00% $833K 2024-08-02 $7.02

🏢 Other funds also holding RXRX

As of 2026 Q1 — sorted by position size

Green Alpha Advisors, LLC 3Y 0.46% Values First Advisors, Inc. 3Y 0.12% KIECKHEFER GROUP LLC 0.11% Cherry Creek Investment Advisors, Inc. 3Y 0.09% 180 WEALTH ADVISORS, LLC 3Y 7Y 0.06% R Squared Ltd 0.05% PROFUND ADVISORS LLC 3Y 7Y 0.04% Interchange Capital Partners, LLC 3Y 0.04% Powell Investment Advisors, LLC 3Y 0.03% Accel Wealth Management 3Y 0.03%

FAQ About COMMONS CAPITAL, LLC and RXRX

These are the practical questions this page is built to answer before you even open the full history table.

How long has COMMONS CAPITAL, LLC reported owning RXRX?

COMMONS CAPITAL, LLC reported RXRX across 8 quarterly 13F filings, from 2024 Q2 through 2026 Q1.

What was the largest reported RXRX position in COMMONS CAPITAL, LLC's portfolio?

The largest reported portfolio weight for RXRX was 1.00% in 2024 Q2.

What is the latest reported RXRX position on this page?

The most recent filing on this page is 2026 Q1, when COMMONS CAPITAL, LLC reported 10,620 shares, equal to 0.03% of portfolio, with an estimated market value of $33K.

What does the chart on this RXRX ownership page compare?

The chart compares COMMONS CAPITAL, LLC's quarterly RXRX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did COMMONS CAPITAL, LLC time their RXRX position?

Based on 13F filing dates vs. subsequent RXRX price moves, COMMONS CAPITAL, LLC correctly timed 4 out of 7 reported position changes (57%). The annualised alpha on RXRX relative to SPY over the holding period was -44.6%.

← Back to COMMONS CAPITAL, LLC Holdings